Tata Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tata Chemicals reported a massive consolidated net loss of ₹1,715 crore for FY26 versus a profit of ₹387 crore in FY25, driven by exceptional items totaling ₹11,956 crore. The exceptional items include a ₹1,837 crore goodwill impairment for US operations due to adverse market conditions and geopolitical headwinds, ₹65 crore additional costs from the UK Lostock plant closure, and ₹54 crore impact from new labour codes. Revenue from operations declined marginally to ₹14,584 crore from ₹14,887 crore. Underlying operating profit before exceptional items was ₹330 crore. The company declared an unchanged dividend of ₹11 per share (110%). Statutory auditors BSR & Co. LLP issued an unmodified opinion on both consolidated and standalone results.
The exceptional items (primarily goodwill impairment and plant closure costs) resulted in a massive bottom-line loss despite reasonable operational revenue. The ₹1,837 crore impairment signals permanent destruction of shareholder value in the US business. Despite the loss, the dividend payout signals management confidence, but the stock may remain under pressure due to the impairment and ongoing UK closure costs.